Is BCRX a good stock to own? Find out who bought BioCryst Pharmaceuticals, who sold BioCryst Pharmaceuticals (BCRX) stock, and who holds a large position in BioCryst Pharmaceuticals.

• Baker Bros. Advisors owns 5.56M shares worth $6.62M
• RA Capital Management owns 1.50M shares worth $5.97M
• Vanguard owns 1.46M shares worth $1.74M
• TPG Group Holdings owns 1.16M shares worth $1.65M
• TPG Capital owns 1.16M shares worth $3.21M
• Driehaus Capital Management owns 702175 shares worth $2.98M
• STATE STREET CORPORATION owns 663203 shares worth $789211
• T. Rowe Price Associates owns 615000 shares worth $873300
• Barclays owns 516100 shares worth $2.49M
• Technical Financial Services owns 426417 shares worth $507436
• VHCP Management owns 392990 shares worth $467658
• SMITH ASSET MANAGEMENT owns 244350 shares worth $970.07M
• TIAA-CREF Investment Management owns 235008 shares worth $279659
• JPMORGAN CHASE & CO owns 191350 shares worth $759659
• Bridgeway Capital Management owns 160000 shares worth $227200
• Hutchin Hill Capital owns 150000 shares worth $726000
• Renaissance Technologies owns 149003 shares worth $591541
• CalPERS owns 146400 shares worth $174216
• Jacobs Levy Equity Management owns 141776 shares worth $201321
• FRANKLIN STREET ADVISORS INC /NC owns 139000 shares worth $165410
• Geode Capital Management owns 137941 shares worth $164149
• Millennium Management owns 137351 shares worth $545283
• Two Sigma Investments owns 130384 shares worth $517624
• D. E. Shaw & Co owns 128473 shares worth $152882
• Frank Russell Company owns 119790 shares worth $457597
• UBS AG owns 111904 shares worth $134284
• Wellington Management Company owns 107663 shares worth $456491
• Bank of America Corporation owns 98385 shares worth $140690
• Spark Investment Management owns 92300 shares worth $108914
• NUMERIC INVESTORS owns 92200 shares worth $390928
• Charles Schwab Investment Management owns 91400 shares worth $127046

• Toronto-Dominion Bank sold on March 31, 2012
• Paradigm Asset Management Company sold on June 30, 2011
• WEISS MULTI-STRATEGY ADVISERS sold on March 31, 2011
• BAM Capital sold on Dec. 31, 2010
• Tradeworx sold on Dec. 31, 2009

• BioMarin Pharmaceutical (BMRN)
• XenoPort (XNPT)
• Gilead Sciences (GILD)
• Array BioPharma (ARRY)
• Onyx Pharmaceuticals (ONXX)
• ArQule (ARQL)
• BioCryst Pharmaceuticals (BCRX)
• Exelixis (EXEL)
• Salix Pharmaceuticals (SLXP)
• Vanda Pharmaceuticals (VNDA)
• Cubist Pharmaceuticals (CBST)
• Sequenom (SQNM)
• Amicus Therapeutics (FOLD)
• BioDelivery Sciences International (BDSI)
• Spectrum Pharmaceuticals (SPPI)
• AVEO Pharmaceuticals (AVEO)
• ZIOPHARM Oncology (ZIOP)
• Chelsea Therapeutics International (CHTP)
• Derma Sciences (DSCI)
• ACADIA Pharmaceuticals (ACAD)
• Discovery Laboratories (DSCOD)